Latest News & Features
Americas
Pharmaceutical company Allergan has received approval from the US Food and Drug Administration to launch a generic version of a cholesterol drug owned by AstraZeneca. 5 May 2016
Americas
CRISPR is only part of the gene editing story, and by studying the patents associated with all of the various methods, a much clearer picture of the entire field can be generated, says Tony Trippe, senior patent analyst for Thomson Reuters. 5 May 2016
Big Pharma
Law firm Cooley has hired Colm Murphy as a partner in the firm’s life sciences patent counselling and prosecution practice in London. 4 May 2016
Asia-Pacific
Australia’s patent system is “poorly targeted” and protection for pharmaceutical inventions is “excessive”, according to a government advisory committee. 4 May 2016
Americas
A judge assessing a patent dispute between Merck and Gilead centring on hepatitis C treatments has allowed Gilead to submit new evidence of jurors allegedly being misled. 3 May 2016
Africa
The Biotechnology Innovation Organization has welcomed the US Trade Representative’s “Special 301 Report”, which it said “aims to advance global IP rights in biotechnology in a number of constructive ways”. 29 April 2016
Africa
Advocate group Médecins Sans Frontières delivered a suitcase full of syringes to the London headquarters of pharmaceutical company GSK in protest at the price of a pneumonia vaccine. 28 April 2016
Africa
Ahead of the English Court of Appeal’s hearing in May in the Warner-Lambert case on second medical use patents, Charlotte Weekes and Tamsin Cornwell of Pinsent Masons examine some of the unanswered questions. 28 April 2016
Americas
Patent litigation related to Abbreviated New Drug Applications has increased by nearly 70% in the last two years, a report has claimed. 27 April 2016
Americas
Pharmaceutical company Takeda has recovered a domain name that is confusingly similar to its trademark. 26 April 2016